As New York’s adult-use cannabis market continues to evolve, the Type 3 Branding License opens a unique pathway for businesses to build and promote cannabis brands without owning or operating a dispensary. This presentation will explore the purpose and scope of the Type 3 license, including who it’s for, what it permits, and how it fits into the broader regulatory framework. Attendees will gain a clear understanding of the opportunities this license presents for brand development, strategic partnerships, and market visibility.
In addition to the licensing overview, this session will cover effective marketing strategies tailored specifically for cannabis businesses in New York. Topics will include navigating advertising restrictions, building brand identity in a regulated environment, leveraging packaging and product storytelling, and connecting with target audiences through compliant channels.
This session offers practical insights for creating a brand that resonates with consumers while remaining aligned with state regulations. Whether you’re planning to launch a cannabis product or grow your existing brand presence, this session will equip you with the knowledge to move forward confidently and strategically.
Dr Sherry Boodram, CEO and Founder CannDelta
I’m Dr. Sherry Boodram, CEO and Co-Founder of CannDelta Inc., where I help businesses navigate the complex world of cannabis regulations and licensing. With a background in the federal government’s cannabis program, I bring deep expertise in inspections, licensing application reviews, and regulatory compliance.
My passion lies in helping clients launch and grow compliant cannabis businesses. I offer strategic guidance on litigation support, mergers and acquisitions, regulatory audits, and inspections. I also specialize in quality management systems and process optimization, helping companies improve efficiency while maintaining high standards.
Beyond the Canadian market, I contribute to the development of international cannabis policies and regulations, supporting companies looking to expand globally. I hold a Ph.D. in Chemistry and certifications in cannabis law and pharmaceutical regulatory affairs, which strengthen my technical and regulatory insight.
I serve as an independent board advisor for a publicly traded cannabis company and am an elected board member of a regulatory affairs association. As a recognized industry leader, I’m often invited to speak at conferences and in the media. I also lead educational workshops and training sessions, sharing knowledge to support and empower others in the cannabis space.